Omnicare Inc. has been slammed with a $50 million penalty for its role in systematically distributing controlled substances to patients at long-term care facilities without proper prescriptions, according to the Drug Enforcement Administration (DEA).
The DEA investigation revealed that Omnicare’s pharmacy facilities regularly dispensed prescription drugs to residents of long-term care facilities, ignoring practitioner-prescribed guidelines. The case underscores the need for stricter oversight in healthcare facilities.
Assistant United States Attorneys Kent W. Penhallurick and Steven J. Paffilas received the Director’s Award for Superior Service by an Assistant United States Attorney – Civil, while DEA Special Agent Scott Brinks was recognized with a Commendation for his pivotal role in the investigation.
The fine imposed on Omnicare is one of the largest penalties ever levied against a healthcare provider for such violations. The case serves as a stark reminder of the potential consequences when corporate negligence endangers public health.
“This penalty sends a clear message that the illegal distribution of controlled substances in healthcare settings will not be tolerated,” stated a DEA spokesperson.
The investigation and subsequent settlement mark another significant victory for law enforcement agencies committed to protecting the elderly and ensuring the integrity of our healthcare system.
Related Federal Cases
Key Facts
- State: Ohio
- Agency: DOJ USAO
- Category: Fraud & Financial Crimes|Public Corruption
- Source: Official Source ↗
🔒 Get the grimiest stories delivered weekly. Subscribe free →
Browse More
MORE FEDERAL CRIME NEWS
US NewsUS NewsUS NewsUS News